Decisions about add-on reimbursement for medical devices in France in December 2018

07

Jan 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2018. The decisions were brought for ten (10) medical devices.

One (1) decision was released regarding prostheses:

  • GLASSBONE INJECTABLE PUTTY, injectable synthetic bone substitute (application for registration, rejected because the available data do not establish the interest for this product)

One (1) decision was released regarding cardiovascular devices:

  • CRT 8000, triple chamber pacemaker (canceled)

Eight (8) decisions were released regarding other devices:

  • IALUSET PLUS, cream, and compresses (Hearing under article R165-5 of the Social Security Code)
  • SIR-Spheres, (application for amendment of the registration conditions, approved)
  • ALBER E-PILOT, traction device with electric drive for a manual wheelchair user (application for registration, rejected because the available data do not establish the interest for this product)
  • IN.PACT ADMIRAL, paclitaxel-eluting balloon (application for amendment of the registration conditions, approved)
  • SENTRY 1200 ST, automatic motorized air mattress with constant pressure and / or dynamic pressure of more than 15 cm of air thickness (application for renewal of registration, approved)
  • SYNCHROMED II (reference 8709SC), programmable implantable pump with the variable flow (canceled)
  • SPECTRA WaveWriter, implantable and rechargeable system of medullary stimulation (application for registration, approved)
  • EDEN, lubricated male condoms (application for registration, approved)

See the full list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more